Артериальная гипертензия у пациентов с посттравматическим стрессовым расстройством

Пациенты с артериальной гипертензией (АГ) и посттравматическим стрессовым расстройством (ПТСР) в настоящее время относятся к мало известной широкому кругу практикующих врачей категории больных. Частота сочетания АГ и ПТСР в общей популяции и среди кардиологических пациентов явно недооценена, а их взаимное влияние, особенности развития и течения АГ при ПТСР, тактика выбора медикаментозного лечения недостаточно освещены в отечественной медицинской литературе. В статье представлен обзор литературы, посвященной изучению клинических особенностей развития и течения АГ у пациентов с ПТСР и подходов к лечению таких пациентов на основании анализа источников с использованием баз данных eLibrary.ru и PubMed. В поиске литературы использованы следующие ключевые слова: артериальная гипертензия, посттравматическое стрессовое расстройство, сердечно-сосудистые заболевания, патогенез, лечение. Всего найдено 200 полнотекстовых источников литературы, для составления обзора использовано 60 источников, наиболее подходящих по тематике.

1. Кобалава Ж.Д., Конради А.О., Недогода С.В., Шляхто Е.В., Арутюнов Г.П., Баранова Е.И. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(9):230-329. DOI: 10.15829/1560-4071-2024-6117

2. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal. 2024;45(38):3912–4018. DOI: 10.1093/eurheartj/ehae178

3. Xiao Z-L, Yang M, Chen X-B, Xie X-M, Chen M-F. Personalized antihypertensive treatment guided by pharmacogenomics in China. Cardiovascular Diagnosis and Therapy. 2022;12(5):635–45. DOI: 10.21037/cdt-22-154

4. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology. 2018;71(19):e127–248. DOI: 10.1016/j.jacc.2017.11.006

5. Kessler RC. Posttraumatic Stress Disorder in the National Comorbidity Survey. Archives of General Psychiatry. 1995;52(12):1048–60. DOI: 10.1001/archpsyc.1995.03950240066012

6. Seal KH, Metzler TJ, Gima KS, Bertenthal D, Maguen S, Marmar CR. Trends and Risk Factors for Mental Health Diagnoses Among Iraq and Afghanistan Veterans Using Department of Veterans Affairs Health Care, 2002–2008. American Journal of Public Health. 2009;99(9):1651–8. DOI: 10.2105/AJPH.2008.150284

7. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Посттравматическое стрессовое расстройство. 2023. Доступно на: https://cr.minzdrav.gov.ru/view-cr/753_1

8. Edmondson D, Von Känel R. Post-traumatic stress disorder and cardiovascular disease. The Lancet Psychiatry. 2017;4(4):320–9. DOI: 10.1016/S2215-0366(16)30377-7

9. Kiphuth IC, Utz KS, Noble AJ, Köhrmann M, Schenk T. Increased Prevalence of Posttraumatic Stress Disorder in Patients After Transient Ischemic Attack. Stroke. 2014;45(11):3360–6. DOI: 10.1161/STROKEAHA.113.004459

10. Krantz DS, Shank LM, Goodie JL. Post-traumatic stress disorder (PTSD) as a systemic disorder: Pathways to cardiovascular disease. Health Psychology. 2022;41(10):651–62. DOI: 10.1037/hea0001127

11. Edmondson D, Richardson S, Falzon L, Davidson KW, Mills MA, Neria Y. Posttraumatic Stress Disorder Prevalence and Risk of Recurrence in Acute Coronary Syndrome Patients: A Meta-analytic Review. PLoS ONE. 2012;7(6):e38915. DOI: 10.1371/journal.pone.0038915

12. Rosman L, Sico JJ, Lampert R, Gaffey AE, Ramsey CM, Dziura J et al. Posttraumatic Stress Disorder and Risk for Stroke in Young and Middle-Aged Adults: A 13-Year Cohort Study. Stroke. 2019;50(11):2996–3003. DOI: 10.1161/STROKEAHA.119.026854

13. Granado NS, Smith TC, Swanson GM, Harris RB, Shahar E, Smith B et al. Newly Reported Hypertension After Military Combat Deployment in a Large Population-Based Study. Hypertension. 2009;54(5):966–73. DOI: 10.1161/HYPERTENSIONAHA.109.132555

14. Goodwin RD, Stein MB. Association between childhood trauma and physical disorders among adults in the United States. Psychological Medicine. 2004;34(3):509–20. DOI: 10.1017/S003329170300134X

15. Sumner JA, Kubzansky LD, Elkind MSV, Roberts AL, Agnew-Blais J, Chen Q et al. Trauma Exposure and Posttraumatic Stress Disorder Symptoms Predict Onset of Cardiovascular Events in Women. Circulation. 2015;132(4):251–9. DOI: 10.1161/CIRCULATIONAHA.114.014492

16. Buckley TC, Kaloupek DG. A Meta-Analytic Examination of Basal Cardiovascular Activity in Posttraumatic Stress Disorder. Psychosomatic Medicine. 2001;63(4):585–94. DOI: 10.1097/00006842-200107000-00011

17. Burg MM, Brandt C, Buta E, Schwartz J, Bathulapalli H, Dziura J et al. Risk for Incident Hypertension Associated With Posttraumatic Stress Disorder in Military Veterans and the Effect of Posttraumatic Stress Disorder Treatment. Psychosomatic Medicine. 2017;79(2):181–8. DOI: 10.1097/PSY.0000000000000376

18. Cohen BE. Association of Cardiovascular Risk Factors With Mental Health Diagnoses in Iraq and Afghanistan War Veterans Using VA Health Care. JAMA. 2009;302(5):489–92. DOI: 10.1001/jama.2009.1084

19. Butterfield MI, Forneris CA, Feldman ME, Beckham JC. Hostility and functional health status in women veterans with and without posttraumatic stress disorder: A preliminary study. Journal of Traumatic Stress. 2000;13(4):735–41. DOI: 10.1023/A:1007874620024

20. Kibler JL, Joshi K, Ma M. Hypertension in Relation to Posttraumatic Stress Disorder and Depression in the US National Comorbidity Survey. Behavioral Medicine. 2009;34(4):125–32. DOI: 10.3200/BMED.34.4.125-132

21. Shalev AY, Sahar T, Freedman S, Peri T, Glick N, Brandes D et al. A Prospective Study of Heart Rate Response Following Trauma and the Subsequent Development of Posttraumatic Stress Disorder. Archives of General Psychiatry. 1998;55(6):553–9. DOI: 10.1001/archpsyc.55.6.553

22. Yehuda R, LeDoux J. Response Variation following Trauma: A Translational Neuroscience Approach to Understanding PTSD. Neuron. 2007;56(1):19–32. DOI: 10.1016/j.neuron.2007.09.006

23. Pole N. The psychophysiology of posttraumatic stress disorder: A meta-analysis. Psychological Bulletin. 2007;133(5):725–46. DOI: 10.1037/0033-2909.133.5.725

24. McFall ME, Veith RC, Murburg MM. Basal sympathoadrenal function in posttraumatic distress disorder. Biological Psychiatry. 1992;31(10):1050–6. DOI: 10.1016/0006-3223(92)90097-J

25. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice. Journal of the American College of Cardiology. 2005;45(5):637–51. DOI: 10.1016/j.jacc.2004.12.005

26. Meewisse M-L, Reitsma JB, De Vries G-J, Gersons BPR, Olff M. Cortisol and post-traumatic stress disorder in adults: Systematic review and meta-analysis. British Journal of Psychiatry. 2007;191(5):387–92. DOI: 10.1192/bjp.bp.106.024877

27. Pace TWW, Heim CM. A short review on the psychoneuroimmunology of posttraumatic stress disorder: From risk factors to medical comorbidities. Brain, Behavior, and Immunity. 2011;25(1):6–13. DOI: 10.1016/j.bbi.2010.10.003

28. Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo J et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. The Lancet Psychiatry. 2015;2(11):1002–12. DOI: 10.1016/S2215-0366(15)00309-0

29. Breslau N, Davis GC, Schultz LR. Posttraumatic Stress Disorder and the Incidence of Nicotine, Alcohol, and Other Drug Disorders in Persons Who Have Experienced Trauma. Archives of General Psychiatry. 2003;60(3):289–94. DOI: 10.1001/archpsyc.60.3.289

30. Zen AL, Whooley MA, Zhao S, Cohen BE. Post-traumatic stress disorder is associated with poor health behaviors: Findings from the Heart and Soul Study. Health Psychology. 2012;31(2):194–201. DOI: 10.1037/a0025989

31. Kronish IM, Edmondson D, Li Y, Cohen BE. Post-traumatic stress disorder and medication adherence: Results from the Mind Your Heart Study. Journal of Psychiatric Research. 2012;46(12):1595–9. DOI: 10.1016/j.jpsychires.2012.06.011

32. Michopoulos V, Vester A, Neigh G. Posttraumatic stress disorder: A metabolic disorder in disguise? Experimental Neurology. 2016;284(Pt B):220–9. DOI: 10.1016/j.expneurol.2016.05.038

33. McFarlane AC. Post‐traumatic stress disorder is a systemic illness, not a mental disorder: is Cartesian dualism dead? Medical Journal of Australia. 2017;206(6):248–9. DOI: 10.5694/mja17.00048

34. Koenen KC, Sumner JA, Gilsanz P, Glymour MM, Ratanatharathorn A, Rimm EB et al. Post-traumatic stress disorder and cardiometabolic disease: improving causal inference to inform practice. Psychological Medicine. 2017;47(2):209–25. DOI: 10.1017/S0033291716002294

35. Scherrer JF, Salas J, Friedman MJ, Cohen BE, Schneider FD, Lustman PJ et al. Clinically meaningful posttraumatic stress disorder (PTSD) improvement and incident hypertension, hyperlipidemia, and weight loss. Health Psychology. 2020;39(5):403–12. DOI: 10.1037/hea0000855

36. Conversano C, Orrù G, Pozza A, Miccoli M, Ciacchini R, Marchi L et al. Is Mindfulness-Based Stress Reduction Effective for People with Hypertension? A Systematic Review and Meta-Analysis of 30 Years of Evidence. International Journal of Environmental Research and Public Health. 2021;18(6):2882. DOI: 10.3390/ijerph18062882

37. LoSavio ST, Beckham JC, Wells SY, Resick PA, Sherwood A, Coffman CJ et al. The effect of reducing posttraumatic stress disorder symptoms on cardiovascular risk: Design and methodology of a randomized clinical trial. Contemporary Clinical Trials. 2021;102:106269. DOI: 10.1016/j.cct.2021.106269

38. Stonerock GL, Blumenthal JA. Role of Counseling to Promote Adherence in Healthy Lifestyle Medicine: Strategies to Improve Exercise Adherence and Enhance Physical Activity. Progress in Cardiovascular Diseases. 2017;59(5):455–62. DOI: 10.1016/j.pcad.2016.09.003

39. Arnsten AFT, Wang MJ, Paspalas CD. Neuromodulation of Thought: Flexibilities and Vulnerabilities in Prefrontal Cortical Network Synapses. Neuron. 2012;76(1):223–39. DOI: 10.1016/j.neuron.2012.08.038

40. Jackman SL, Regehr WG. The Mechanisms and Functions of Synaptic Facilitation. Neuron. 2017;94(3):447–64. DOI: 10.1016/j.neuron.2017.02.047

41. Cojocariu SA, Maștaleru A, Sascău RA, Stătescu C, Mitu F, Leon-Constantin MM. Neuropsychiatric Consequences of Lipophilic Beta-Blockers. Medicina. 2021;57(2):155. DOI: 10.3390/medicina57020155

42. Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, Den Boer JA et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology. 2014;28(5):403–39. DOI: 10.1177/0269881114525674

43. Kindt M, Soeter M, Vervliet B. Beyond extinction: erasing human fear responses and preventing the return of fear. Nature Neuroscience. 2009;12(3):256–8. DOI: 10.1038/nn.2271

44. Armstrong C, Kapolowicz MR. A Preliminary Investigation on the Effects of Atenolol for Treating Symptoms of Anxiety. Military Medicine. 2020;185(11–12):e1954–60. DOI: 10.1093/milmed/usaa170

45. Fleminger S, Greenwood RR, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database of Systematic Reviews. 2006;4:CD003299. DOI: 10.1002/14651858.CD003299.pub2

46. Carnovale C, Perrotta C, Baldelli S, Cattaneo D, Montrasio C, Barbieri SS et al. Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects. Cardiovascular Research. 2023;119(3):647–67. DOI: 10.1093/cvr/cvac110

47. Eddin LE, Preyra R, Ahmadi F, Jafari A, Omrani MA, Muanda FT. β‐Blockers and risk of neuropsychiatric disorders: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 2025;91(2):325–37. DOI: 10.1111/bcp.16361

48. Kessing LV, Rytgaard HC, Ekstrøm CT, Torp-Pedersen C, Berk M, Gerds TA. Antihypertensive Drugs and Risk of Depression: A Nationwide Population-Based Study. Hypertension. 2020;76(4):1263–79. DOI: 10.1161/HYPERTENSIONAHA.120.15605

49. Riemer TG, Villagomez Fuentes LE, Algharably EAE, Schäfer MS, Mangelsen E, Fürtig M-A et al. Do β-Blockers Cause Depression?: Systematic Review and Meta-Analysis of Psychiatric Adverse Events During β-Blocker Therapy. Hypertension. 2021;77(5):1539–48. DOI: 10.1161/HYPERTENSIONAHA.120.16590

50. Liu F, Havens J, Yu Q, Wang G, Davisson RL, Pickel VM et al. The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress. International Journal of Physiology, Pathophysiology and Pharmacology. 2012;4(1):28–35. PMID: 22461954

51. Von Bohlen Und Halbach O, Albrecht D. The CNS renin-angiotensin system. Cell and Tissue Research. 2006;326(2):599–616. DOI: 10.1007/s00441-006-0190-8

52. Phillips MI, De Oliveira EM. Brain renin angiotensin in disease. Journal of Molecular Medicine. 2008;86(6):715–22. DOI: 10.1007/s00109-008-0331-5

53. Vian J, Pereira C, Chavarria V, Köhler C, Stubbs B, Quevedo J et al. The renin–angiotensin system: a possible new target for depression. BMC Medicine. 2017;15(1):144. DOI: 10.1186/s12916-017-0916-3

54. Williams LJ, Pasco JA, Kessing LV, Quirk SE, Fernandes BS, Berk M. Angiotensin Converting Enzyme Inhibitors and Risk of Mood Disorders. Psychotherapy and Psychosomatics. 2016;85(4):250–2. DOI: 10.1159/000444646

55. Kessing LV, Rytgaard HC, Gerds TA, Berk M, Ekstrøm CT, Andersen PK. New drug candidates for depression – a nationwide population‐based study. Acta Psychiatrica Scandinavica. 2019;139(1):68–77. DOI: 10.1111/acps.12957

56. Brownstein DJ, Salagre E, Köhler C, Stubbs B, Vian J, Pereira C et al. Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials. Australian & New Zealand Journal of Psychiatry. 2018;52(1):24–38. DOI: 10.1177/0004867417721654

57. Mohite S, Sanches M, Teixeira AL. Exploring the Evidence Implicating the Renin-Angiotensin System (RAS) in the Physiopathology of Mood Disorders. Protein & Peptide Letters. 2020;27(6):449–55. DOI: 10.2174/0929866527666191223144000

58. Kronish IM, Lin JJ, Cohen BE, Voils CI, Edmondson D. Posttraumatic Stress Disorder and Medication Nonadherence in Patients With Uncontrolled Hypertension. JAMA Internal Medicine. 2014;174(3):468–70. DOI: 10.1001/jamainternmed.2013.12881

59. Бойцов С.А., Карпов Ю.А., Логунова Н.А., Бурцев Ю.П., Квасников Б.Б., Хомицкая Ю.В. Пути повышения приверженности к антигипертензивной терапии. Российский кардиологический журнал. 2022;27(9):76-82. DOI: 10.15829/1560-4071-2022-5202

60. Кобалава Ж.Д., Квасников Б.Б., Бурцев Ю.П. от лица исследователей PRIDE. Эффективность и переносимость фиксированной комбинации бисопролола/периндоприла у пациентов с артериальной гипертензией, стабильной стенокардией и инфарктом миокарда в анамнезе: результаты исследования PRIDE. Кардиология. 2024;64(6):22-33. DOI: 10.18087/cardio.2024.6.n2662